IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,652,000 | -72.3% | 1,510,792 | -69.2% | 0.03% | -70.3% |
| Q2 2022 | $56,511,000 | -6.2% | 4,901,198 | +2.3% | 0.10% | +11.0% |
| Q1 2022 | $60,273,000 | +27.0% | 4,791,196 | +17.7% | 0.09% | +33.8% |
| Q4 2021 | $47,471,000 | -33.7% | 4,071,262 | -25.8% | 0.07% | -38.7% |
| Q3 2021 | $71,615,000 | +17.5% | 5,483,569 | +15.8% | 0.11% | +16.8% |
| Q2 2021 | $60,971,000 | +62.9% | 4,737,415 | +41.5% | 0.10% | +53.2% |
| Q1 2021 | $37,437,000 | -1.8% | 3,348,532 | 0.0% | 0.06% | -8.8% |
| Q4 2020 | $38,140,000 | +102.4% | 3,348,532 | +59.8% | 0.07% | +83.8% |
| Q3 2020 | $18,848,000 | -3.5% | 2,095,332 | +10.7% | 0.04% | -11.9% |
| Q2 2020 | $19,537,000 | +7.0% | 1,893,132 | +4.6% | 0.04% | -12.5% |
| Q1 2020 | $18,256,000 | +382.8% | 1,809,332 | +423.5% | 0.05% | +500.0% |
| Q2 2019 | $3,781,000 | +55.3% | 345,600 | +162.1% | 0.01% | +60.0% |
| Q3 2018 | $2,434,000 | -66.3% | 131,858 | -65.1% | 0.01% | -37.5% |
| Q2 2018 | $7,228,000 | – | 378,092 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |